TELA Bio (TELA) Tax Provisions (2025 - 2026)
TELA Bio (TELA) recorded quarterly Tax Provisions of $60000.0 in Q1 2026, up 5900.0% quarter-over-quarter from $1000.0 in Q4 2025, and up 15.38% on a YoY basis from $52000.0 in Q1 2025.
TELA Bio (TELA) Tax Provisions (2025 - 2026) Analysis & Trends
TELA Bio's Tax Provisions history runs 2 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 15.38% year-over-year to $60000.0; the TTM figure through Mar 2026 stood at $94000.0 (changed N/A YoY), while the FY2025 annual figure was $86000.0, up 159.72% from the prior year.
- Tax Provisions was $60000.0 for Q1 2026 at TELA Bio, up from $1000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $60000.0 in Q1 2026 to a low of $1000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 254.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -51.51 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 70.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 84.20 Mn |
| 10 | TELA Bio | 48.23 Mn | 8.69 Mn | 12.52 Mn | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | 52,000.00 |